Approval · Notice of Compliance 9039 · 2007
REBIF: Notice of Compliance 9039
Issued September 24, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9039
- Date
- September 24, 2007
- Company
- Emd Serono Canada Inc
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing process and new product formulation
- Therapeutic class
- Immunomodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REBIF | Not yet assigned | — |
Medicinal ingredients
- INTERFERON BETA-1A 8.8 MCG per 0.2ML
- INTERFERON BETA-1A 22 MCG per 0.5ML
- INTERFERON BETA-1A 44 MCG per 0.5ML